Immunogen, Inc.
IMGN
Revenue
9.29M
▲9.29M∞%
3 Months ChangeAssets
822.10M
▲107.77M▲15.09%
3 Months ChangeLiabilities
260.51M
▲37.02M▲16.56%
3 Months ChangeFree Cash Flow
-73.93M
▼-32.22M▼-77.25%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-02-12
Form 8-K
ID: 0001104659-24-013712
2024-02-08
Form 8-K
ID: 0001104659-24-011926
2024-01-31
Form 8-K
ID: 0001104659-24-008800
2024-01-29
Form 8-K
ID: 0001104659-24-007784
2024-01-24
Form 8-K
ID: 0001104659-24-006287
2024-01-08
Form 8-K
ID: 0001104659-24-002242
2023-11-30
Form 8-K
ID: 0001104659-23-122415
2023-11-02
Form 10-Q
ID: 0001558370-23-017411
2023-11-02
Form 8-K
ID: 0001558370-23-017308
2023-09-18
Form 8-K
ID: 0001558370-23-015834